Concurrent interactome and metabolome analysis reveals role of AKT1 in central carbon metabolism

Abstract

ObjectiveSignal transduction not only initiates entry into the cell cycle, but also reprograms the cell’s metabolism. To control abnormalities in cell proliferation, both the aspects should be taken care of, thus pleiotropic signaling molecules are considered as crucial modulators. Considering this, we investigated the role of AKT1 in central carbon metabolism. The role of AKT1 has already been established in the process of cell cycle, but its contribution to the central carbon metabolism is sparsely studied.ResultsTo address this, we combined the metabolomics and proteomics approaches. In accordance to our hypothesis, we found that the AKT1 kinase activity is regulating the levels of acetyl CoA through pyruvate dehydrogenase complex. Further, the decreased levels of acetyl CoA and dependency of acetyl CoA acetyl transferase protein on AKT1 kinase activity was also found to perturb the synthesis rate of palmitic acid which is a representative of fatty acid. This was analyzed in the present study using lipid labeling method through mass spectrometry.Electronic supplementary materialThe online version of this article (10.1186/s13104-018-3364-z) contains supplementary material, which is available to authorized users.

Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis

“…In order to analyze the metabolic state of Mtb depleted with DNA gyrase expression, we estimated the levels of metabolites by LC-MS/MS, as described in the materials and methods. Metabolites in both the control and gyr(-) were quantified by using concentration-dependent standard curves for each metabolite as described earlier (Gupta et al, 2018). Those small molecules which exhibit minimal variation ( P < 0.05) in six biological samples were examined for fold-change in their levels between the two strains (Supplementary Dataset 4).…”

Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells

“…22,23 Glucose carbon entry into the TCA cycle via PDH was also inhibited by uprosertib, consistent with previous work that suggests a direct interaction between PDH subunit B and AKT1 and that silencing of AKT1 could reduce PDH flux from 13 C labelled glucose. 35 By contrast exogenous lactate incorporation into citrate was maintained in cells treated with uprosertib. Furthermore, lactic acidosis stimulated an increase in respiration and respiratory capacity in our cell models.…”